NCT05189639View on ClinicalTrials.gov

A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

RecruitingOBSERVATIONAL

Enrollment

165

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

November 17, 2027

Study Completion Date

November 17, 2027

Conditions

Acute Myeloid Leukemia

Trial Locations (1)

Unknown

RECRUITING

Seoul national university hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05189639 - A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter